Sysmex Corporation (SSMXY)
SSMXY Stock Price Chart
Explore Sysmex Corporation interactive price chart. Choose custom timeframes to analyze SSMXY price movements and trends.
SSMXY Company Profile
Discover essential business fundamentals and corporate details for Sysmex Corporation (SSMXY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
17 Oct 2011
Employees
10.04K
Website
https://www.sysmex.co.jpCEO
Kaoru Asano
Description
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
SSMXY Financial Timeline
Browse a chronological timeline of Sysmex Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 5 Nov 2025
Earnings released on 6 Aug 2025
EPS came in at $0.05 falling short of the estimated $0.12 by -57.19%, while revenue for the quarter reached $716.75M , missing expectations by -11.21%.
Earnings released on 14 May 2025
EPS came in at $0.12 falling short of the estimated $0.16 by -25.79%, while revenue for the quarter reached $974.86M , missing expectations by -1.65%.
Earnings released on 12 Feb 2025
EPS came in at $0.17 surpassing the estimated $0.16 by +9.61%, while revenue for the quarter reached $812.27M , missing expectations by -1.02%.
Earnings released on 6 Nov 2024
EPS came in at $0.16 surpassing the estimated $0.16 by +2.37%, while revenue for the quarter reached $853.35M , missing expectations by -2.25%.
Dividend declared on 30 Sept 2024
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 18 Dec 2024.
Earnings released on 6 Aug 2024
EPS came in at $0.11 surpassing the estimated $0.10 by +7.32%, while revenue for the quarter reached $696.98M , missing expectations by -0.02%.
Earnings released on 6 Jun 2024
EPS came in at $0.16 falling short of the estimated $0.17 by -4.07%, while revenue for the quarter reached $889.82M , beating expectations by +6.21%.
Stock split effective on 2 Apr 2024
Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 27 Mar 2024
A dividend of $0.13 per share was announced, adjusted to $0.09. The dividend was paid on 9 Jul 2024.
Earnings released on 9 Feb 2024
EPS came in at $0.13 falling short of the estimated $0.16 by -18.44%, while revenue for the quarter reached $813.66M , beating expectations by +6.26%.
Earnings released on 8 Nov 2023
EPS came in at $0.15 surpassing the estimated $0.13 by +16.10%, while revenue for the quarter reached $785.25M , beating expectations by +0.53%.
Dividend declared on 28 Sept 2023
A dividend of $0.14 per share was announced, adjusted to $0.10. The dividend was paid on 19 Dec 2023.
Earnings released on 8 Aug 2023
EPS came in at $0.10 falling short of the estimated $0.13 by -20.76%, while revenue for the quarter reached $659.78M , missing expectations by -8.03%.
Earnings released on 11 May 2023
EPS came in at $0.13 falling short of the estimated $0.19 by -31.65%, while revenue for the quarter reached $843.45M , missing expectations by -7.21%.
Dividend declared on 30 Mar 2023
A dividend of $0.15 per share was announced, adjusted to $0.10. The dividend was paid on 11 Jul 2023.
Earnings released on 9 Feb 2023
EPS came in at $0.13 falling short of the estimated $0.18 by -25.88%, while revenue for the quarter reached $807.33M , beating expectations by +0.39%.
Earnings released on 9 Nov 2022
EPS came in at $0.19 surpassing the estimated $0.05 by +254.87%, while revenue for the quarter reached $746.87M , beating expectations by +3.88%.
Dividend declared on 29 Sept 2022
A dividend of $0.15 per share was announced, adjusted to $0.10. The dividend was paid on 20 Dec 2022.
Earnings released on 4 Aug 2022
EPS came in at $0.10 falling short of the estimated $0.11 by -11.03%, while revenue for the quarter reached $632.93M , missing expectations by -3.49%.
Earnings released on 12 May 2022
EPS came in at $0.15 surpassing the estimated $0.15 by +2.11%, while revenue for the quarter reached $857.70M , beating expectations by +3.76%.
Dividend declared on 29 Mar 2022
A dividend of $0.14 per share was announced, adjusted to $0.10. The dividend was paid on 12 Jul 2022.
Earnings released on 10 Feb 2022
EPS came in at $0.15 falling short of the estimated $0.25 by -39.86%, while revenue for the quarter reached $783.76M , beating expectations by +0.27%.
Earnings released on 10 Nov 2021
EPS came in at $0.18 , while revenue for the quarter reached $802.51M .
Dividend declared on 28 Sept 2021
A dividend of $0.16 per share was announced, adjusted to $0.11. The dividend was paid on 21 Dec 2021.
Earnings released on 6 Aug 2021
EPS came in at $0.15 , while revenue for the quarter reached $714.08M .
Earnings released on 12 May 2021
EPS came in at $0.15 , while revenue for the quarter reached $843.39M .
Dividend declared on 29 Mar 2021
A dividend of $0.16 per share was announced, adjusted to $0.11. The dividend was paid on 13 Jul 2021.
Earnings released on 3 Feb 2021
EPS came in at $0.16 , while revenue for the quarter reached $771.94M .
Earnings released on 5 Nov 2020
EPS came in at $0.12 , while revenue for the quarter reached $678.01M .
Dividend declared on 28 Sept 2020
A dividend of $0.17 per share was announced, adjusted to $0.11. The dividend was paid on 16 Dec 2020.
SSMXY Stock Performance
Access detailed SSMXY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.